Mona Holmes is an editor at Eater Southern California/Southwest, a regular contributor at KCRW radio, and a 2022 James Beard Award nominee. The mother-daughter team behind Little Tokyo’s popular ...

WOIPPY, France, May 11, 2026--(BUSINESS WIRE)--Regulatory News: ABL Diagnostics (Paris:ABLD)(Euronext Compartment B – ISIN: FR001400AHX6), a company specialized in in vitro diagnostics, today ...

WOIPPY, France--(BUSINESS WIRE)--Regulatory News: ABL Diagnostics (Paris:ABLD) announces that its main shareholder, Advanced Biological Laboratories (ABL), a Luxembourg-based diagnostics company, has ...

Let’s face it: As we age, our vision and balance aren’t what they used to be. These changes to our senses can be minor annoyances but can also lead to injury, from stubbed toes to serious falls.

Asset-based lending (ABL) helps businesses borrow against receivables, inventory, real estate, and equipment. Learn how ABL works, who it’s right for, pros and cons, and where to find the best lenders ...

South Korea’s newest billionaire is Lee Sang-hoon, founder of Seoul-based ABL Bio, after it struck a $2.6 billion licensing and joint research deal with Eli Lilly for its bispecific antibody ...

ABL Bio Inc. inked a license and research agreement with Eli Lilly and Co. worth up to $2.6 billion to develop multiple therapeutics using the Grabody-B platform. Under the terms announced Nov. 12, ...

Neok Bio has exited stealth with $75 million to take a pair of bispecific antibody-drug conjugates sourced from ABL Bio into the clinic. ABL, a Korean biotech that is partnered with companies ...

The “top-selling 3D printer brand in the world” is running an anniversary sale that has buyers saving big bucks. Are you looking to try your hand at 3D printing? Or, maybe, you want to upgrade your ...

ABL Bio Inc. announced April 7 that it sealed a potential £2.075 billion (US$2.65 billion) license deal with GSK plc, granting GSK global rights to use ABL’s blood-brain barrier (BBB) penetrating ...

ABL Bio CEO CEO Sang Hoon Lee said an agreement with GSK "will serve as a great opportunity to strengthen ABL Bio's position in the neurodegenerative disease treatment market." (iStock / Getty Images ...